The Exploratory/Developmental Bioengineering Research Grants (EBRG) funding program supports projects that demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of…
Continue ReadingExploratory/Developmental Bioengineering Research Grants [Deadline: Applications are due on 16 February 2025]
The purpose of this grant is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically…
Continue ReadingMobile Health: Technology and Outcomes in Low and Middle Income Countries [Deadline: Letters of intent are due 21 February 2025. Applications are due on 21 March 2025]
The University of Utah is now accepting applications for the Wilkes Climate Launch Prize to highlight top global ideas for combating climate change. The goal is to develop effective climate…
Continue Reading2025 Wilkes Climate Launch Prize [Deadline: 25 February 2025]
This initiative aims to support micro, small, and medium-sized enterprises (MSMEs) in ASEAN member states pioneering innovative, carbon-neutral solutions to urban challenges. Funding Organization: The U.S. Department of State, through…
Continue ReadingSmart Cities Business Innovation Fund 2.0 [Deadline: 15 January 2025 for Track 1, and 15 February 2025 for Track 2]
The Informatics Tools for the Pangenome from the National Institutes of Health (NIH) supports the development of informatics tools to facilitate uptake and scientific use of the human pangenome reference…
Continue ReadingInformatics Tools for the Pangenome [Deadline: Letters of intent are due 3 February 2025. Applications close 3 March 2025]
The Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD funding from the National Institutes of Health (NIH) supports research projects that apply existing or newly developed artificial intelligence (AI) and…
Continue ReadingArtificial Intelligence in Pre-clinical Drug Development for AD/ADRD [Deadline: Letters of intent are due on 13 January 2025 and full applications are due on 13 February 2025.]